UA109661C2 - Фармацевтична композиція співкристалів трамадолу і коксибів - Google Patents

Фармацевтична композиція співкристалів трамадолу і коксибів

Info

Publication number
UA109661C2
UA109661C2 UAA201300099A UAA201300099A UA109661C2 UA 109661 C2 UA109661 C2 UA 109661C2 UA A201300099 A UAA201300099 A UA A201300099A UA A201300099 A UAA201300099 A UA A201300099A UA 109661 C2 UA109661 C2 UA 109661C2
Authority
UA
Ukraine
Prior art keywords
tramadol
celecoxib
crystals
pharmaceutical compositions
medicaments
Prior art date
Application number
UAA201300099A
Other languages
English (en)
Russian (ru)
Inventor
Рансані Луїс Солер
Альдеа Альберт Фалівене
Original Assignee
Лабораторьос Дель Др. Естеве, С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лабораторьос Дель Др. Естеве, С.А. filed Critical Лабораторьос Дель Др. Естеве, С.А.
Publication of UA109661C2 publication Critical patent/UA109661C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide

Abstract

Даний винахід стосується пероральних фармацевтичних композицій, що містять співкристали трамадолу і целекоксибу, способів їх отримання і їх застосування як лікарських засобів, більш конкретно, для лікування болю.
UAA201300099A 2010-06-04 2011-06-03 Фармацевтична композиція співкристалів трамадолу і коксибів UA109661C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10384002A EP2392319A1 (en) 2010-06-04 2010-06-04 Pharmaceutical compositions of co-crystals of tramadol and coxibs
PCT/EP2011/002749 WO2011151080A1 (en) 2010-06-04 2011-06-03 Pharmaceutical compositions of co-crystals of tramadol and coxibs

Publications (1)

Publication Number Publication Date
UA109661C2 true UA109661C2 (uk) 2015-09-25

Family

ID=42358396

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201300099A UA109661C2 (uk) 2010-06-04 2011-06-03 Фармацевтична композиція співкристалів трамадолу і коксибів

Country Status (32)

Country Link
US (1) US8846744B2 (uk)
EP (3) EP2392319A1 (uk)
JP (1) JP5800016B2 (uk)
KR (1) KR101556700B1 (uk)
CN (1) CN102946871B (uk)
AR (1) AR081774A1 (uk)
AU (1) AU2011260608B2 (uk)
BR (1) BR112012030704A2 (uk)
CA (1) CA2798090C (uk)
CO (1) CO6660469A2 (uk)
CY (1) CY1118813T1 (uk)
DK (1) DK2575778T3 (uk)
EC (1) ECSP13012368A (uk)
ES (1) ES2622192T3 (uk)
HR (1) HRP20170594T1 (uk)
HU (1) HUE033999T2 (uk)
IL (1) IL222731A (uk)
LT (1) LT2575778T (uk)
MX (1) MX351507B (uk)
MY (1) MY156859A (uk)
NZ (1) NZ603457A (uk)
PL (1) PL2575778T3 (uk)
PT (1) PT2575778T (uk)
RS (1) RS55878B1 (uk)
RU (1) RU2567843C2 (uk)
SG (1) SG185385A1 (uk)
SI (1) SI2575778T1 (uk)
TN (1) TN2012000515A1 (uk)
TW (1) TWI508722B (uk)
UA (1) UA109661C2 (uk)
WO (1) WO2011151080A1 (uk)
ZA (1) ZA201208767B (uk)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2177215A1 (en) 2008-10-17 2010-04-21 Laboratorios Del. Dr. Esteve, S.A. Co-crystals of tramadol and NSAIDs
EP2311446A1 (en) * 2009-10-16 2011-04-20 Laboratorios Del. Dr. Esteve, S.A. Compositions comprising Tramadol and Celecoxib in the treatment of pain
US9138425B2 (en) 2013-03-12 2015-09-22 Patheon Inc. Drug delivery system to increase bioavailability
EP3137060B2 (en) 2014-05-01 2023-12-20 Sun Pharmaceutical Industries Ltd Extended release suspension compositions
US10258583B2 (en) 2014-05-01 2019-04-16 Sun Pharmaceutical Industries Limited Extended release liquid compositions of guanfacine
US9962336B2 (en) 2014-05-01 2018-05-08 Sun Pharmaceutical Industries Limited Extended release suspension compositions
WO2015166472A1 (en) * 2014-05-01 2015-11-05 Sun Pharmaceutical Industries Limited Extended release liquid compositions of metformin
WO2016016845A1 (en) 2014-07-30 2016-02-04 Sun Pharmaceutical Industries Limited Dual-chamber pack
US20180104197A9 (en) 2014-05-01 2018-04-19 Sun Pharmaceutical Industries Limited Extended release liquid compositions of metformin
WO2016046693A1 (en) * 2014-09-25 2016-03-31 Nathwani Sandeep Vinodkumar A co-processed pharmaceutical excipient
CN104276960B (zh) * 2014-09-26 2016-09-28 安徽省逸欣铭医药科技有限公司 盐酸他喷他多和塞来昔布共晶及其组合物和制备方法
US10238803B2 (en) 2016-05-02 2019-03-26 Sun Pharmaceutical Industries Limited Drug delivery device for pharmaceutical compositions
US10369078B2 (en) 2016-05-02 2019-08-06 Sun Pharmaceutical Industries Limited Dual-chamber pack for pharmaceutical compositions
WO2018031577A1 (en) * 2016-08-09 2018-02-15 Autotelic Llc Fixed dose combination for pain relief without edema
DE102016012746A1 (de) 2016-10-25 2018-04-26 WindplusSonne GmbH Vorprodukte zur Herstellung von porösen, mineralischen Leichtbaumaterialien, Verfahren zur Herstellung von porösen, mineralischen Leichtbaumaterialien und ihre Verwendung
CA3045128A1 (en) 2016-12-14 2018-06-21 Druggability Technologies Ip Holdco Limited Pharmaceutical composition containing celecoxib
CN107595792A (zh) * 2017-11-06 2018-01-19 刘丽 一种盐酸他喷他多塞来昔布片剂及其制备方法
CN110101673A (zh) * 2019-05-07 2019-08-09 安徽金太阳生化药业有限公司 一种盐酸曲马多分散片的制备方法
SG11202111390TA (en) 2019-05-14 2021-11-29 Esteve Pharmaceuticals Sa Use of co-crystals of tramadol and celecoxib for treating pain while reducing the abuse liability of tramadol
CN112007024A (zh) * 2019-05-28 2020-12-01 江苏恒瑞医药股份有限公司 艾瑞昔布与曲马多联合在制备治疗疼痛的药物中的用途
CN115251264B (zh) * 2022-08-05 2023-11-21 齐鲁工业大学 含桑叶提取物的共结晶粉末功能性饮料及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1156855A1 (en) * 1999-03-01 2001-11-28 Ortho-McNeil Pharmaceutical, Inc. Composition comprising a tramadol material and a selective cox-2 inhibitor drug
DE10014588A1 (de) * 2000-03-27 2001-10-04 Basf Ag Wirkstoffhaltige Schwimmformen enthaltend Polyvinylacetat und Polyvinylpyrrolidon, deren Verwendung und Herstellung
US20030105141A1 (en) * 2001-04-17 2003-06-05 Ping Gao Finely self-emulsifiable pharmaceutical composition
PT1478366E (pt) * 2002-02-19 2009-03-10 Adcock Ingram Ltd Combinações farmacêuticas de meloxicam, fosfato de codeína e paracetamol
JP2005154334A (ja) * 2003-11-25 2005-06-16 Toa Yakuhin Kk アズレンスルホン酸塩水溶液剤
DE102006044694A1 (de) * 2006-09-22 2008-03-27 Krewel Meuselbach Gmbh Perorale feste Schmerzmittelzubereitung
WO2008085674A1 (en) * 2007-01-04 2008-07-17 Transform Pharmaceuticals, Inc. Pharmaceutical compositions comprising celecoxib co-crystals
CN101254180B (zh) * 2008-03-28 2010-11-10 辽宁正鑫药物研究有限公司 一种内容物为半固体组合物的尼莫地平胶囊剂及制备方法
EP2177215A1 (en) 2008-10-17 2010-04-21 Laboratorios Del. Dr. Esteve, S.A. Co-crystals of tramadol and NSAIDs

Also Published As

Publication number Publication date
CA2798090A1 (en) 2011-12-08
SI2575778T1 (sl) 2017-07-31
AU2011260608A1 (en) 2012-11-22
CA2798090C (en) 2017-02-28
JP5800016B2 (ja) 2015-10-28
PT2575778T (pt) 2017-04-21
MX2012014087A (es) 2013-02-27
LT2575778T (lt) 2017-04-10
IL222731A0 (en) 2012-12-31
BR112012030704A2 (pt) 2016-09-13
KR20130093015A (ko) 2013-08-21
CN102946871B (zh) 2019-03-08
AR081774A1 (es) 2012-10-17
EP3158994A1 (en) 2017-04-26
IL222731A (en) 2016-05-31
MX351507B (es) 2017-10-18
ZA201208767B (en) 2013-07-31
CO6660469A2 (es) 2013-04-30
US20130109659A1 (en) 2013-05-02
PL2575778T3 (pl) 2017-09-29
TW201143760A (en) 2011-12-16
EP2575778A1 (en) 2013-04-10
EP2575778B1 (en) 2017-01-18
HUE033999T2 (en) 2018-01-29
US8846744B2 (en) 2014-09-30
DK2575778T3 (en) 2017-04-18
CN102946871A (zh) 2013-02-27
NZ603457A (en) 2014-10-31
RU2567843C2 (ru) 2015-11-10
AU2011260608B2 (en) 2015-05-07
HRP20170594T1 (hr) 2017-06-16
EP2392319A1 (en) 2011-12-07
KR101556700B1 (ko) 2015-10-01
RS55878B1 (sr) 2017-08-31
ECSP13012368A (es) 2013-01-31
MY156859A (en) 2016-04-15
JP2013530952A (ja) 2013-08-01
RU2012157256A (ru) 2014-07-20
TN2012000515A1 (en) 2014-04-01
SG185385A1 (en) 2012-12-28
WO2011151080A1 (en) 2011-12-08
TWI508722B (zh) 2015-11-21
ES2622192T3 (es) 2017-07-05
CY1118813T1 (el) 2018-03-07

Similar Documents

Publication Publication Date Title
UA109661C2 (uk) Фармацевтична композиція співкристалів трамадолу і коксибів
TN2015000278A1 (en) Autotaxin inhibitors
IN2012DN01435A (uk)
NZ608116A (en) Triazine-oxadiazoles
GB201118656D0 (en) New compounds
PH12014501514A1 (en) New azetidine derivatives, pharmaceutical compositions and uses thereof
MD20150043A2 (ro) Inhibitori ai histon-demetilazelor
IN2012DN02805A (uk)
MY161088A (en) Agonists of gpr40
MX343706B (es) Derivados heterocíclicos novedosos.
MX2015003653A (es) Derivados de amida del acido benzoimidazol-carboxilico como moduladores del receptor apj.
IN2012MN02591A (uk)
MX349004B (es) Nuevos compuestos.
MX366899B (es) Nuevos compuestos.
PH12015500713A1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
MX348823B (es) Formulaciones estables de linaclotida.
MX347734B (es) Anticuerpos anti-s100a4 y usos aplicaciones terapéuticas.
IN2012DN01434A (uk)
MX2019012939A (es) Formulaciones que contienen linaclotida para administracion oral.
WO2013061004A8 (fr) Nouveaux composés di-substitués de la diamino-3,4-cyclobutène-3-dione-1,2 utiles dans le traitement de pathologies médiées par des chimiokines
GEP20156231B (en) Agomelatine hydrochloride hydrate and preparation there of
GEP201706621B (en) Benzamides
HK1173380A1 (en) Co-crystals of tramadol and coxibs
MX2012002631A (es) Capsulas con aroma.
TN2012000075A1 (en) Co-crystals of tramadol and coxibs